Medicine as common as aspirin may improve outcomes for those who contract cerebral malaria, say researchers from Johns Hopkins. This conclusion is based on a recent discovery in which the researchers "found that red blood cells infected with the malaria parasite activate platelets to secrete the PF4 protein, which triggers the immune system to inflame blood vessels and obstruct capillaries in the brain -- both hallmarks of cerebral malaria."

Related Summaries